Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 75 results.
User Information
Export Records
  1. 1.   Antiretroviral Therapy within Two Years of HIV Acquisition is Associated with Fewer Viral Blips: A Retrospective Analysis of Over 20 Years of Data from the U.S. Military HIV Natural History Study
  2. Crowell, Trevor A; Hsieh, Hsing-Chuan; Wang, Xun; Chu, Xiuping; Gayle, Britt; Berjohn, Catherine M; Blaylock, Jason M; Yabes, Joseph M; Larson, Derek T; Powers,John; O'Connell, Robert J; Ganesan, Anuradha; Agan, Brian K
  3. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2025, Mar 10;
  1. 2.   MicroRNA Profiles in Monocyte-Derived Macrophages Generated by Interleukin-27 and Human Serum: Identification of a Novel HIV-Inhibiting and Autophagy-Inducing MicroRNA
  2. Imamichi, Tomozumi; Goswami, Suranjana; Hu, Xiaojun; Laverdure, Sylvain; Yang, Jun; Qiu, Ju; Chen, Qian; Sherman, Brad T.; Chang, Weizhong
  3. International Journal of Molecular Sciences. 2021, Jan 28; 22(3):
  1. 3.   A Synthetic Mirror Image of Kalata B1 Reveals that Cyclotide Activity Is Independent of a Protein Receptor
  2. Sando, L.; Henriques, S. T.; Foley, F.; Simonsen, S. M.; Daly, N. L.; Hall, K. N.; Gustafson, K. R.; Aguilar, M. I.; Craik, D. J.
  3. Chembiochem. 2011, Nov; 12(16): 2456-2462.
  1. 4.   Investigation of Griffithsin's Interactions with Human Cells Confirms Its Outstanding Safety and Efficacy Profile as a Microbicide Candidate
  2. Kouokam, J. C.; Huskens, D.; Schols, D.; Johannemann, A.; Riedell, S. K.; Walter, W.; Walker, J. M.; Matoba, N.; O'Keefe, B. R.; Palmer, K. E.
  3. Plos One. 2011, Aug; 6(8):
  1. 5.   Biological evaluation of imidazolium- and ammonium-based salts as HIV-1 integrase inhibitors
  2. Maddali, K.; Kumar, V.; March, C.; Pommier, Y.; Malhotra, S. V.
  3. Medchemcomm. 2011, Feb; 2(2): 143-150.
  1. 6.   Synthesis and biological evaluation of novel dihydro-aryl/alkylsulfanyl-cyclohexylmethyl-oxopyrimidines (S-DACOs) as high active anti-HIV agents
  2. He, Y. P.; Long, J.; Zhang, S. S.; Li, C.; Lai, C. C.; Zhang, C. S.; Li, D. X.; Zhang, D. H.; Wang, H.; Cai, Q. Q.; Zheng, Y. T.
  3. Bioorganic & Medicinal Chemistry Letters. 2011, Jan; 21(2): 694-697.
  1. 7.   Topology of the disulfide bonds in the antiviral lectin scytovirin
  2. Moulaei, T.; Stuchlik, O.; Reed, M.; Yuan, W. R.; Pohl, J.; Lu, W. Y.; Haugh-Krumpe, L.; O'Keefe, B. R.; Wlodawer, A.
  3. Protein Science. 2010, Sep; 19(9): 1649-1661.
  1. 8.   Design and Synthesis of Isonucleosides Constructed on a 2-Oxa-6-thiabicyclo[3.2.0]heptane Scaffold
  2. Yoshimura, Y.; Asami, K.; Imamichi, T.; Okuda, T.; Shiraki, K.; Takahata, H.
  3. Journal of Organic Chemistry. 2010, Jun; 75(12): 4161-4171.
  1. 9.   Virus maturation as a new HIV-1 therapeutic target
  2. Adamson, C. S.; Salzwedel, K.; Freed, E. O.
  3. Expert opinion on therapeutic targets. 2009, Aug; 13(8): 895-908.
  1. 10.   Anti-HIV-1 therapeutics: from FDA-approved drugs to hypothetical future targets
  2. Adamson, C. S.; Freed, E. O.
  3. Molecular Interventions. 2009, Apr; 9(2): 70-4.
  1. 11.   RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy
  2. Shao, W.; Kearney, M.; Maldarelli, F.; Mellors, J. W.; Stephens, R. M.; Lifson, J. D.; KewalRamani, V. N.; Ambrose, Z.; Coffin, J. M.; Palmer, S. E.
  3. Retrovirology. 2009 6: 101.
  1. 12.   Synthesis of conformationally locked carbocyclic nucleoside phosphonates to probe the active site of HIV-1 RT
  2. Saneyoshi, H.; Vu, B. C.; Hughes, S. H.; Boyer, P. L.; Sarafianos, S. G.; Marquez, V. E.
  3. Nucleic acids symposium series (2004). 2008 (52): 623-4.
  1. 13.   Atomic-resolution crystal structure of the antiviral lectin scytovirin
  2. Moulaei, T.; Botos, I.; Ziolkowska, N. E.; Bokesch, H. R.; Krumpe, L. R.; McKee, T. C.; O'Keefe, B. R.; Dauter, Z.; Wlodawer, A.
  3. Protein Science. 2007, Dec; 16(12): 2756-2760.
  1. 14.   Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide
  2. Emau, P.; Tian, B.; O'Keefa, B. R.; Mori, T.; McMahon, J. B.; Palmer, K. E.; Jiang, Y.; Bekele, G.; Tsai, C. C.
  3. Journal of Medical Primatology. 2007, Aug; 36(4-5): 244-253.
  1. 15.   The novel fold of scytovirin reveals a new twist for antiviral entry inhibitors
  2. McFeeters, R. L.; Xiong, C. Y.; O'Keefe, B. R.; Bokesch, H. R.; McMahon, J. B.; Ratner, D. M.; Castelli, R.; Seeberger, P. H.; Byrd, R. A.
  3. Journal of Molecular Biology. 2007, Jun; 369(2): 451-461.
  1. 16.   Crystallographic, thermodynamic, and molecular modeling studies of the mode of binding of oligosaccharides to the potent antiviral protein griffithsin
  2. Ziolkowska, N. E.; Shenoy, S. R.; O'Keefe, B. R.; McMahon, J. B.; Palmer, K. E.; Dwek, R. A.; Wormald, M. R.; Wlodawer, A.
  3. Proteins-Structure Function and Bioinformatics. 2007, May; 67(3): 661-670.
  1. 17.   Nucleosides with self-complementary hydrogen-bonding motifs: Synthesis and base-pairing studies of two nucleosides containing the imidazo 4,5-d pyridazine ring system
  2. Ujjinamatada, R. K.; Paulman, R. L.; Ptak, R. G.; Hosmane, R. S.
  3. Bioorganic & Medicinal Chemistry. 2006, Sep; 14(18): 6359-6367.
  1. 18.   Antibody-based inhibitors of HIV infection
  2. Choudhry, V.; Zhang, M. Y.; Dimitrova, D.; Prabakaran, P.; Dimitrov, A. S.; Fouts, T. R.; Dimitrov, D. S.
  3. Expert Opinion on Biological Therapy. 2006, MAY; 6(5): 523-531.
  1. 19.   Recombinant production of anti-HIV protein, griffithsin, by auto-induction in a fermentor culture
  2. Giomarelli, B.; Schumacher, K. M.; Taylor, T. E.; Sowder, R. C.; Hartley, J. L.; McMahon, J. B.; Mori, T.
  3. Protein Expression and Purification. 2006, MAY; 47(1): 194-202.
  1. 20.   Antisense treatments for biothreat agents
  2. Warfield, K. L.; Panchal, R. G.; Aman, M. J.; Bavari, S.
  3. Current Opinion in Molecular Therapeutics. 2006, Apr; 8(2): 93-103.
  1. 21.   Overexpression and purification of scytovirin, a potent, novel anti-HIV protein from the cultured cyanobacterium Scytonema varium
  2. Xiong, C. Y.; O'Keefe, B. R.; Botos, I.; Wlodawer, A.; McMahon, J. B.
  3. Protein Expression and Purification. 2006, Apr; 46(2): 233-239.
  1. 22.   Inactivation of retroviruses with preservation of structural integrity by targeting the hydrophobic domain of the viral envelope
  2. Raviv, Y.; Viard, M.; Bess, J. W.; Chertova, E.; Blumenthal, R.
  3. Journal of Virology. 2005, OCT; 79(19): 12394-12400.
  1. 23.   Sphingolipids: Modulators of HIV-1 infection and pathogenesis
  2. Rawat, S. S.; Johnson, B. T.; Puri, A.
  3. Bioscience Reports. 2005, OCT; 25(5-6): 329-343.
  1. 24.   Isolation and characterization of novel cyclotides from Viola hederaceae - Solution structure and anti-HIV activity of vhl-1, a leaf-specific expressed cyclotide
  2. Chen, B.; Colgrave, M. L.; Daly, N. L.; Rosengren, K. J.; Gustafson, K. R.; Craik, D. J.
  3. Journal of Biological Chemistry. 2005, JUN 10; 280(23): 22395-22405.
  1. 25.   Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A
  2. Witvrouw, M.; Fikkert, V.; Hantson, A.; Pannecouque, C.; O'Keefe, B. R.; McMahon, J.; Stamatatos, L.; De Clercq, E.; Bolmstedt, A.
  3. Journal of Virology. 2005, JUN; 79(12): 7777-7784.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel